Trexquant Investment LP - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$616,000
-15.8%
49,529
-7.4%
0.10%
-40.5%
Q3 2016$732,000
-14.3%
53,500
-53.7%
0.16%
+45.5%
Q2 2016$854,000
+78.7%
115,558
+51.2%
0.11%
+166.7%
Q4 2015$478,000
-29.8%
76,426
-7.3%
0.04%
-44.7%
Q2 2015$681,000
-33.6%
82,408
-44.8%
0.08%
-58.0%
Q4 2014$1,025,000149,2000.18%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,331,100$23,281,0008.28%
DAFNA Capital Management LLC 191,215$3,344,0004.89%
Redmile Group, LLC 1,277,109$22,337,0003.94%
BB BIOTECH AG 3,115,371$54,488,0003.92%
SECTORAL ASSET MANAGEMENT INC 5,292,682$92,569,0002.74%
IRONWOOD INVESTMENT MANAGEMENT LLC 565,956$9,899,0001.76%
OAK RIDGE INVESTMENTS LLC 2,645,781$46,275,0001.45%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,104$22,127,0001.04%
Tekla Capital Management LLC 412,965$7,223,0000.98%
Private Capital Advisors, Inc. 127,600$2,232,0000.83%
View complete list of ARIAD PHARMACEUTICALS INC shareholders